ATE22657T1 - Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung. - Google Patents

Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung.

Info

Publication number
ATE22657T1
ATE22657T1 AT83303427T AT83303427T ATE22657T1 AT E22657 T1 ATE22657 T1 AT E22657T1 AT 83303427 T AT83303427 T AT 83303427T AT 83303427 T AT83303427 T AT 83303427T AT E22657 T1 ATE22657 T1 AT E22657T1
Authority
AT
Austria
Prior art keywords
prostaglandin
preparation
emulsion containing
emulsion
action
Prior art date
Application number
AT83303427T
Other languages
English (en)
Inventor
Yutaka Mizushima
Hironaka Aihara
Susumu Otomo
Kazumasa Yokoyama
Hiroyuki Okamoto
Tadakazu Suyama
Original Assignee
Taisho Pharmaceutical Co Ltd
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14390874&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE22657(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd, Green Cross Corp filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE22657T1 publication Critical patent/ATE22657T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT83303427T 1982-06-18 1983-06-14 Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung. ATE22657T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57104814A JPS58222014A (ja) 1982-06-18 1982-06-18 プロスタグランジンｅ↓１脂肪乳剤
EP83303427A EP0097481B1 (de) 1982-06-18 1983-06-14 Prostaglandin E1, enthaltende Emulsion und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE22657T1 true ATE22657T1 (de) 1986-10-15

Family

ID=14390874

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83303427T ATE22657T1 (de) 1982-06-18 1983-06-14 Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung.

Country Status (8)

Country Link
US (1) US4493847A (de)
EP (1) EP0097481B1 (de)
JP (1) JPS58222014A (de)
KR (1) KR880001756B1 (de)
AT (1) ATE22657T1 (de)
CA (1) CA1203173A (de)
DE (1) DE3366662D1 (de)
ZA (1) ZA834458B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
JPS6253922A (ja) * 1985-09-02 1987-03-09 Tetsuzo Sugizaki 腎炎予防・治療剤
JPS63246330A (ja) * 1987-03-31 1988-10-13 Isamu Koyama 腎臓温阻血障害改善剤
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5082664A (en) * 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5811118A (en) * 1987-05-22 1998-09-22 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
JP2600726B2 (ja) * 1987-11-30 1997-04-16 大正製薬株式会社 微粒子脂肪乳剤
JP2926749B2 (ja) 1989-04-25 1999-07-28 吉富製薬株式会社 プロスタグランジン含有液状組成物
JPH0669966B2 (ja) * 1989-07-05 1994-09-07 株式会社ミドリ十字 血管造影補助剤
JPH03101622A (ja) * 1989-09-11 1991-04-26 Green Cross Corp:The 肝炎予防治療剤
US5194670A (en) * 1989-10-16 1993-03-16 Yutaka Mizushima, Asahi Glass Company Ltd. Emulsion of lipid containing a prostaglandin analogue
JP2602964B2 (ja) * 1989-10-16 1997-04-23 裕 水島 プロスタグランジン類縁体およびその脂肪乳剤
KR0151704B1 (ko) * 1989-11-27 1998-10-15 아만 히데아키 지방 유제
US4966779A (en) * 1989-12-21 1990-10-30 Basf Corporation Stable, water miscible emulsion comprising a fat-soluble vitamin
US5882678A (en) * 1990-01-12 1999-03-16 The Liposome Co, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites
DK0512916T3 (da) * 1991-05-07 1999-09-20 Liposome Co Inc Liposomale prostaglandinformuleringer
JP2851704B2 (ja) * 1993-02-03 1999-01-27 帝人株式会社 脳血栓症治療のための薬学的組成物
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
SE9303281D0 (sv) * 1993-10-07 1993-10-07 Astra Ab New formulation
US5840328A (en) * 1994-01-11 1998-11-24 The Liposome Company, Inc. Treatment using arachidonic acid metabolite and particulate formulations
WO1997009986A1 (fr) * 1995-09-13 1997-03-20 Nippon Shinyaku Co., Ltd. Preparation lyophilisee contenant de la pge1 et son procede de production
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
DE19607296A1 (de) * 1996-02-27 1997-08-28 Kodak Ag Heftvorrichtung zum Zusammenheften von Blättern
DE19645657A1 (de) * 1996-11-06 1998-05-28 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung, Verfahren zur Herstellung einer derartigen Zusammensetzung und Verwendung derselben
WO1999009992A1 (fr) 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
DE602004019466D1 (de) * 2003-04-07 2009-04-02 Canon Kk Magnetischer Toner
US8334321B2 (en) 2006-09-05 2012-12-18 Q.P. Corporation Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
ES2466865T3 (es) 2010-05-21 2014-06-11 Nestec S.A. Dispositivo de distribución de vapor o agua caliente que se puede almacenar
CN103536532A (zh) * 2013-10-25 2014-01-29 北京蓝丹医药科技有限公司 一种前列地尔组合物及其制备方法
US11432674B2 (en) 2017-02-28 2022-09-06 Societe Des Produits Nestle S.A. Dispenser with parallel dispensing paths
CN107137351B (zh) * 2017-06-05 2020-08-04 辅必成（上海）医药科技有限公司 一种稳定的前列地尔乳剂注射液

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT196914163A (es) * 1968-08-29 1971-01-26 Composicion y proceso
US4016290A (en) * 1973-11-12 1977-04-05 The United States Of America As Represented By The United States Energy Research And Development Administration Method of encapsulating polyaminopolycarboxylic acid chelating agents in liposomes
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
US4302459A (en) * 1980-03-19 1981-11-24 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤

Also Published As

Publication number Publication date
JPS58222014A (ja) 1983-12-23
JPH0157094B2 (de) 1989-12-04
EP0097481A1 (de) 1984-01-04
ZA834458B (en) 1984-03-28
DE3366662D1 (en) 1986-11-13
KR880001756B1 (ko) 1988-09-12
EP0097481B1 (de) 1986-10-08
US4493847A (en) 1985-01-15
KR840005019A (ko) 1984-11-03
CA1203173A (en) 1986-04-15

Similar Documents

Publication Publication Date Title
ATE22657T1 (de) Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung.
AT371795B (de) Verfahren zur herstellung von tert.olefinen
AT372390B (de) Verfahren zur herstellung von neuen 4'-jodderivaten von anthracyclinglykosiden
ATE29500T1 (de) Verfahren zur herstellung von nphosphonomethylglycin.
AT376655B (de) Verfahren zur herstellung von neuen glycerinaethern von aminonitrophenolen
AT372382B (de) Verfahren zur herstellung von neuen oxiranylisocyanursaeureverbindungen
ATE21262T1 (de) Verfahren zur herstellung von ursodeoxycholsaeure.
ATA271583A (de) Verfahren zur herstellung von neuen lh-fshreleasingfaktoranaloga
ATA88379A (de) Verfahren zur herstellung detoxifizierter zubereitungen von cytostatika
ATE5719T1 (de) Verfahren zur herstellung von 3-picolin.
ATA731476A (de) Verfahren zur herstellung von pastenextrudierbaren polymerisaten des tetrafluorathylens
AT371469B (de) Verfahren zur herstellung von neuen penamcarbonsaeure-derivaten
AT365567B (de) Verfahren zur herstellung von neuen derivaten des s-carboxybenzyl-l-cysteins
ATA230583A (de) Verfahren zur herstellung von neuen saeurederivaten
AT369758B (de) Verfahren zur herstellung von alkenungesaettigten oligourethanen
AT381492B (de) Verfahren zur herstellung von neuen als antihyper-tensiva verwendbaren 1-phenoxy-3-hydroxyindolylalkylamino-3-propanolverbindungen
ATA815178A (de) Verfahren zur herstellung von neuen derivaten des trans-2,3-dhydro-2-(4-hydroxy-3-methoxyphenyll) -7-methoxy-3-methyl-5-(e)-propenylbenzofurans
AT382370B (de) Verfahren zur herstellung von 2-carboxamiden des 3-methylchinoxalin-n-1,4-dioxid
ATA706679A (de) Verfahren zur herstellung von neuen derivaten des 4-hydroxi-thiazolidin-2-thions
ATE20047T1 (de) Verfahren zur herstellung von aethanol.
AT377255B (de) Verfahren zur herstellung von 1-alkyl- bzw. 1,4-dialkyl-1h-pyrrol-2-essigsaeure-alkylestern
ATE37364T1 (de) Verfahren zur herstellung von ascorbinsaeure.
AT381309B (de) Verfahren zur herstellung von 5z-formen von 2,3,4 -trinor-1,5-inter-m-phenylen-prostacyclinderiva en
ATE21688T1 (de) Verfahren zur herstellung von phenylalkylaminoethylsalicylamid.
ATA770279A (de) Verfahren zur herstellung von neuen n-(5(6)- subst.benzimidazol-2-yl)-carbaminsaeurealkyl- estern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked